Empyrean Capital Partners’s AEON Biopharma AEON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,778
| Closed | -$1.42M | – | 74 |
|
|
2023
Q2 | $1.42M | Hold |
2,778
| – | – | 0.06% | 58 |
|
|
2023
Q1 | $2.03M | Sell |
2,778
-16,666
| -86% | -$12.2M | 0.07% | 73 |
|
|
2022
Q4 | $14.1M | Hold |
19,444
| – | – | 0.44% | 56 |
|
|
2022
Q3 | $13.8M | Hold |
19,444
| – | – | 0.43% | 64 |
|
|
2022
Q2 | $13.7M | Hold |
19,444
| – | – | 0.44% | 78 |
|
|
2022
Q1 | $13.7M | Hold |
19,444
| – | – | 0.3% | 86 |
|
|
2021
Q4 | $13.6M | Hold |
19,444
| – | – | 0.36% | 75 |
|
|
2021
Q3 | $13.6M | Buy |
+19,444
| New | +$13.6M | 0.3% | 86 |
|